Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells
Sushil Kumar, Zexian Zeng, Archis Bagati, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 2050-2071
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Cellular pathways influenced by protein arginine methylation: Implications for cancer
Jian Xu, Stéphane Richard
Molecular Cell (2021) Vol. 81, Iss. 21, pp. 4357-4368
Open Access | Times Cited: 128
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
Qin Wu, Yan Nie, Wail Ba-alawi, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 8, pp. 821-830
Open Access | Times Cited: 90
The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis
Ling-Xian Zhang, Jian Gao, Xiang Long, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 76
Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells
Ce Luo, Rui Zhang, Rui Guo, et al.
Immunity (2025)
Closed Access | Times Cited: 2
Crosstalk between metabolism and epigenetics during macrophage polarization
Kangling Zhang, Chinnaswamy Jagannath
Epigenetics & Chromatin (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
CRISPR screens for functional interrogation of immunity
Hao Shi, John G. Doench, Hongbo Chi
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 363-380
Closed Access | Times Cited: 50
A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
Junyu Long, Dongxu Wang, Anqiang Wang, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 48
The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8+ T cells
Amy E. Baxter, Hua Huang, Josephine R. Giles, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1320-1340.e10
Open Access | Times Cited: 37
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
Zheng-Zheng Yu, Yun-Ya Liu, Wei Zhu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e006345-e006345
Open Access | Times Cited: 23
Inhibition of CARM1‐Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer
Shengjie Feng, Zejun Rao, Jiakun Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 23
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity
Haojie Dong, Xin He, Lei Zhang, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 601-624
Open Access | Times Cited: 12
BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity
Eui‐Jun Kim, Peng Liu, Shengjie Zhang, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 21, pp. 12211-12233
Open Access | Times Cited: 44
CARM1 arginine methyltransferase as a therapeutic target for cancer
Margarida A. Santos, Jee Won Hwang, Mark T. Bedford
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105124-105124
Open Access | Times Cited: 20
Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
Weijing Dai, Jian‐Guo Zhang, Siqi Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics
Michelle Wang, Priscilla Liow, Maria I. Tarazona Guzman, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 4, pp. 744-755
Open Access | Times Cited: 23
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)
Kailiang Wu, Chen Niu, Hanjiao Liu, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 5
Open Access | Times Cited: 14
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
The Role of PRMT5 in Immuno-Oncology
Yoshinori Abe, Takumi Sano, Nobuyuki Tanaka
Genes (2023) Vol. 14, Iss. 3, pp. 678-678
Open Access | Times Cited: 13
CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
Chen Chen, Zehua Wang, Yanru Qin
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 13
The emerging role of CARM1 in cancer
Zizhuo Xie, Yuan Tian, Xiaohan Guo, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1503-1522
Open Access | Times Cited: 5
Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy
Zhuqing Zhang, Zuhao Guo, Xiaowei Xu, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16650-16674
Closed Access | Times Cited: 28
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
Kentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 20
Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
Kai Wang, Chao Yang, Haibin Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines
Yoshinaga Ito, Deng Pan, Wubing Zhang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1186-1209
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top